Key PointsFair Isaac is gaining recognition in the AI fraud-prevention industry.

Key PointsSweetgreen's recent quarter showed negative same-store sales and weaker margins, resetting expectations.

Key PointsNu Holdings and SoFi Technologies have seen significant stock gains over the past year and a half.

Key PointsEach of these five companies disappointed investors in some way after reporting quarterly financial results.

Key PointsThe S&P 500 has advanced 10% year to date despite economic headwinds, slightly more than its return of 9.3% annually over the last four decades.

Key PointsNvidia's stock is up over 1,000% since the start of 2023.

Key PointsNvidia stock has been a great performer in recent years.

Key PointsBitcoin is the world's largest cryptocurrency, accounting for more than half the value of the entire crypto market.

Key PointsPalantir stock has soared 1,900% in recent years.

Key PointsAlphabet's quantum computing efforts dovetail nicely with its AI development.

Key PointsGrowth investors might like other stocks more, but Energy Transfer's growth prospects look good.

(RTTNews) - Takeda Pharmaceutical Company Limited (TAK, TKPHF, 4502.T) announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for VONVENDI [von Willebrand factor (Recombinant)]. The expanded indication now inc

(RTTNews) - New Fortress Energy Inc (NFE) announced Loss for its second quarter of -$555.08 million

In this podcast, Motley Fool analyst Tim Beyers and contributors Travis Hoium and Lou Whiteman discuss:

Explore the exciting world of UnitedHealth (NYSE: UNH) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were the prices of

(RTTNews) - Sky Harbour Group Corporation (SKYH) has closed a $200 million tax-exempt warehouse drawdown committed bank facility with J.P. Morgan as lender and administrative agent.

(RTTNews) - Artelo Biosciences, Inc. (ARTL), a clinical-stage biopharmaceutical company, announced the closing of its underwritten public offering of 640,924 shares of common stock at $4.40 per share and pre-funded warrants to purchase 40,894 shares at $4.399 per warrant.

Key PointsThe company reported earnings per share and revenue ahead of consensus estimates.

Key PointsFew expected the retailer to do as well as it did in its second quarter.

(RTTNews) - Eaton Vance Municipal Bond Fund (EIM) announced preliminary results of its cash tender offer for up to 5 percent of its outstanding common shares, which expired on September 4, 2025.

Key PointsAn analyst initiated coverage of the biotech.

Key PointsThe data center equipment supplier delivers a lesson on how to crush analyst estimates.

Chip growth stays hot despite tariffs. ADI, MX to ride AI, EV and industrial trends for long-term gains.

Key PointsDocusign reported its Q2 earnings, beating Wall Street's targets.

Key PointsSemiconductor reliability is crucial to data centers.